Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

[1] Evobrutinib (Evobrutinib)

[1] Evobrutinib (Evobrutinib) 💬

[1] BTK 💬

[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬

[3] 13, 46, 49 💬

2

Evobrutinib 10mg

[1] Evobrutinib (Evobrutinib)

[1] Evobrutinib (Evobrutinib) 💬

[1] BTK 💬

[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬

[1] 13 💬

3

Evobrutinib 25mg

[1] Evobrutinib (Evobrutinib)

[1] Evobrutinib (Evobrutinib) 💬

[1] BTK 💬

[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬

[1] 13 💬

4

M2951 (Other Name: Evobrutinib)

[1] Evobrutinib (Evobrutinib)

[1] Evobrutinib (Evobrutinib) 💬

[1] BTK 💬

[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬

[1] 49 💬